Changeflow GovPing Pharma & Drug Safety EPO Patent Grant EP3575389B1 - Consumer Product...
Routine Rule Added Final

EPO Patent Grant EP3575389B1 - Consumer Products With Protease Variants

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has granted patent EP3575389B1 for consumer products containing protease variants. This patent, effective March 18, 2026, covers innovations related to detergent compositions and their use in cleaning applications.

What changed

The European Patent Office (EPO) has granted patent EP3575389B1, titled "Consumer Products With Protease Variants." This patent, which becomes effective on March 18, 2026, relates to novel protease variants and their application in consumer products, particularly cleaning agents. The grant signifies the EPO's recognition of the inventive step and industrial applicability of the claimed technology.

For manufacturers in the consumer products sector, especially those involved in detergent formulation, this patent grant may impact product development and market entry. Companies should review the patent's claims to ensure their products do not infringe on the granted intellectual property rights. While this is a patent grant and not a regulatory rule imposing direct compliance obligations, it establishes exclusive rights for the patent holder in designated European states.

Source document (simplified)

← EPO Patent Bulletin

CONSUMER PRODUCTS WITH PROTEASE VARIANTS

Grant EP3575389B1 Kind: B1 Mar 18, 2026

Inventors

SOUTER, Philip Frank, WARD, Glenn Steven, POULOSE, Ayrookaran Joseph, ESTELL, David A, KELLIS, Jr. James T., COLLIER, Katherine D., CASCAO-PEREIRA, Luis Gustavo, ALEKSEYEV, Viktor Yuryevich, AMIN, Neelam S., YAO, Jian, AUGUSTYN, Katherine

IPC Classifications

C11D 3/386 20060101AFI20200127BHEP C12N 9/54 20060101ALI20200127BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Consumer Products With Protease Variants

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3575389B1

Who this affects

Applies to
Manufacturers
Industry sector
3114 Food & Beverage Manufacturing
Activity scope
Product Development Intellectual Property Management
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Intellectual Property Biotechnology

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.